ecoli-uk.com

E.coli O157 & Haemolytic Uraemic Syndrome


Trial of Eculizumab for HUS approved

26th December 2015

The trial for the drug Eculizumab for HUS sufferers has been approved. The study is known as the ECUSTEC. The drug is currently being used by aHUS sufferers. The Charity welcomes the trial which will start in 2016 as it is hoped that it will help improve the outcome for sufferers of HUS. To date there has been no specific treatment.

The Charity is one of the co-applicants for the drug based on the fact that there has been no such treatments previously. Whilst only time will tell whether or not the drug will work, we can only hope that it will be beneficial long term for such sufferers. The trial will take several years to complete.




Page
1 of 48
Next > Last >>

8th October 2024

By email  steve@ecoli-uk.com ... ...read on
9th September 2024

As you are aware, this matter relates to a complaint to the ICO with regard to the UKHSA’s failure to respond to my request for information, made under FOIA, dated 1st July 2024. ... ...read on
13th August 2024

The Information Commissioner’s Office (ICO) now has to decide if the UK Health Security Agency (UKHSA) were correct in handling a new Freedom of information request about the 2022 outbreak of E.coli O157 from lettuce and salad leaves... ...read on
5th July 2024

Confirmed cases rise again to 288 in STEC O145 outbreak (Shiga toxin-producing Escherichia coli) from what is thought to have been caused from salad leaves (lettuce) in sandwiches and wraps. ... ...read on
27th June 2024

The UK Health Security Agency (UKHSA) stated in their press release of today 27... ...read on
Page
1 of 48
Next > Last >>

Designed by Robert Woods. View our Cookie & Privacy Policy